Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide has not received marketing authorisation from the MHRA, EMA, or FDA and cannot be legally prescribed outside authorised clinical trials
Reduced Risk of Obesity-Related Conditions Achieving and maintaining a healthier weight with Semaglutide may lower the risk of conditions such as heart disease, stroke, sleep apnea, and certain types of cancer
All clinical data referenced is sourced to primary literature, Eli Lilly materials, and trial registries
Some of the diagnostic and clinical work exists in non-English literature or specific national contexts, complicating a complete synthesis
US$ 25.14
US$ 27.13
US$ 21.63
US$ 23.91
US$ 28.58
US$ 27.92
US$ 25.49
US$ 26.04
